LTFS
ALPN

Ladenburg Thalmann Financial Services’s Alpine Immune Sciences Inc ALPN Stock Holding History

Ladenburg Thalmann Financial Services’s Portfolio ALPN Stock Details ALPN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-5,615
Closed -$45K – 5355
2018
Q2 		$45K Hold
5,615
– – ﹤0.01% 3331
2018
Q1 		$45K Sell
5,615
-425
-7% -$4.2K ﹤0.01% 3331
2017
Q4 		$68K Buy
+6,040
New +$65.7K ﹤0.01% 3017

Other funds holding ALPN

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TM
Tiger Management New York $22.8M AUM 0.71% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Ladenburg Thalmann Financial Services's ALPN Position: Q3 2018 in Review

Ladenburg Thalmann Financial Services sold out of Alpine Immune Sciences Inc (ALPN) in Q3 2018, closing a stake of 5,615 shares — an estimated $45K sold.

Ladenburg Thalmann Financial Services first reported a position in ALPN in Q4 2017 and held it in 3 quarters. The position peaked at $68K in Q4 2017. 22 funds tracked by Wall St. Rank hold ALPN as of Q3 2018.

  • Ladenburg Thalmann Financial Services reported no remaining Alpine Immune Sciences Inc position as of Q3 2018 after selling out during the quarter.
  • Ladenburg Thalmann Financial Services sold 5,615 Alpine Immune Sciences Inc shares in Q3 2018, an estimated $45K.
  • Ladenburg Thalmann Financial Services first reported a position in Alpine Immune Sciences Inc in Q4 2017 and held it in 3 quarters.
  • Ladenburg Thalmann Financial Services's Alpine Immune Sciences Inc position peaked at $68K in Q4 2017.
  • 22 funds tracked by Wall St. Rank held Alpine Immune Sciences Inc as of Q3 2018.

Based on Ladenburg Thalmann Financial Services's 13F filing for Q3 2018, filed 14 Nov 2018.